Dengue fever
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Consistent with dengue clinical manifestations, with epidemiological history (have been to dengue endemic areas 15 days prior to the onset, dengue cases have occurred in residence), or leukopenia and thrombocytopenia; (2) According to the Guidelines for the diagnosis and treatment of dengue fever(china, 2014), hospitalized patients with highly suspicious of dengue fever mild acute period; (3) To be aged between 16 to 70 years; (4) patients whose under armpit temperatures to be higher than 38.5?; (5) patients who must be voluntary to the trail and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Severe Dengue fever patients; (2) Patients with secondary infection; (3) With diabetes, coronary heart disease, liver cirrhosis, peptic ulcer, asthma, COPD, Mediterranean anemia, chronic renal dysfunction and other underlying diseases, and glucose 6-phosphate dehydrogenase (G-6-PD) deficiency disease; (4) Obesity or severe malnutrition patients; (5) Allergic constitution (allergic to more than 2 types of material allergy), or allgeric to the composition of the drugs in this study; (6) Inclined to hemolysis patients; (7) Have participated in clinical trials of other drugs within the past 3 months; (8) Other conditions that investigators believe are not suitable for the patients to be enrolled; (9) patients are unsuitble for the experiment considered by the doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time of temperature to nomal;nucleic acid detection of serum pathogeni; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of clinical symptoms disappeared;Blood analysis;Serum inflammatory factors;Hospitalization tim; | — |
Countries
Guangdong